The innovative antibody, DISC-0974, shows remarkable specificity for RGMC, the crucial protein playing with human differentiation. Preclinical results suggest that inhibiting RGMC/HFE2 signaling with this therapeutic https://www.targetmol.com/compound/disc_0974